| GO ID | GO:0018108 |
| Ontology | BP |
| GO Term | peptidyl-tyrosine phosphorylation |
| Definition | The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine. |
| Gene Symbol | Description | Entrez ID | Uniprot ID | Chromosomal Location |
|---|---|---|---|---|
|
MAP2K7 |
mitogen-activated protein kinase kinase 7 |
5609 |
O14733 |
chr19: 7,903,843-7,914,478 |
|
EREG |
epiregulin |
2069 |
O14944 |
chr4: 74,365,143-74,388,751 |
|
MUSK |
muscle, skeletal, receptor tyrosine kinase |
4593 |
O15146 |
chr9: 110,668,771-110,801,620 |
|
RIPK2 |
receptor interacting serine/threonine kinase 2 |
8767 |
O43353 |
chr8: 89,757,747-89,791,063 |
|
JAK2 |
Janus kinase 2 |
3717 |
O60674 |
chr9: 4,984,390-5,128,183 |
|
FGF18 |
fibroblast growth factor 18 |
8817 |
O76093 |
chr5: 171,419,656-171,457,623 |
|
ERLIN2 |
ER lipid raft associated 2 |
11160 |
O94905 |
chr8: 37,736,599-37,759,101 |
|
EGFR |
epidermal growth factor receptor |
1956 |
P00533 |
chr7: 55,019,021-55,211,628 |
|
PDGFB |
platelet-derived growth factor beta polypeptide |
5155 |
P01127 |
chr22: 39,223,359-39,244,751 |
|
ERBB2 |
erb-b2 receptor tyrosine kinase 2 |
2064 |
P04626 |
chr17: 39,687,914-39,730,426 |
|
NTRK1 |
neurotrophic tyrosine kinase, receptor, type 1 |
4914 |
P04629 |
chr1: 156,815,640-156,881,850 |
|
INSR |
insulin receptor |
3643 |
P06213 |
chr19: 7,112,255-7,294,034 |
|
FYN |
FYN proto-oncogene, Src family tyrosine kinase |
2534 |
P06241 |
chr6: 111,660,332-111,873,452 |
|
CSF1R |
colony stimulating factor 1 receptor |
1436 |
P07333 |
chr5: 150,053,291-150,113,372 |
|
HSP90AA1 |
heat shock protein 90kDa alpha family class A member 1 |
3320 |
P07900 |
chr14: 102,080,738-102,139,699 |
|
LYN |
LYN proto-oncogene, Src family tyrosine kinase |
4067 |
P07948 |
chr8: 55,879,813-56,014,168 |
|
MET |
MET proto-oncogene, receptor tyrosine kinase |
4233 |
P08581 |
chr7: 116,672,390-116,798,386 |
|
FGF2 |
fibroblast growth factor 2 (basic) |
2247 |
P09038 |
chr4: 122,826,708-122,898,236 |
|
PDGFRB |
platelet-derived growth factor receptor, beta polypeptide |
5159 |
P09619 |
chr5: 150,113,837-150,155,872 |
|
FGR |
FGR proto-oncogene, Src family tyrosine kinase |
2268 |
P09769 |
chr1: 27,612,064-27,635,277 |
|
KIT |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
3815 |
P10721 |
chr4: 54,657,918-54,740,715 |
|
BCR |
breakpoint cluster region |
613 |
P11274 |
chr22: 23,179,704-23,318,037 |
|
FGFR1 |
fibroblast growth factor receptor 1 |
2260 |
P11362 |
chr8: 38,411,138-38,468,834 |
|
PDGFRA |
platelet-derived growth factor receptor, alpha polypeptide |
5156 |
P16234 |
chr4: 54,229,097-54,298,247 |
|
FGF7 |
fibroblast growth factor 7 |
2252 |
P21781 |
chr15: 49,423,096-49,488,775 |
|
FGFR2 |
fibroblast growth factor receptor 2 |
2263 |
P21802 |
chr10: 121,478,334-121,598,458 |
|
ERBB3 |
erb-b2 receptor tyrosine kinase 3 |
2065 |
P21860 |
chr12: 56,079,857-56,103,505 |
|
EPHA3 |
EPH receptor A3 |
2042 |
P29320 |
chr3: 89,107,524-89,482,134 |
|
EPHB2 |
EPH receptor B2 |
2048 |
P29323 |
chr1: 22,710,839-22,921,500 |
|
LTK |
leukocyte receptor tyrosine kinase |
4058 |
P29376 |
chr15: 41,503,638-41,513,887 |
|
WEE1 |
WEE1 G2 checkpoint kinase |
7465 |
P30291 |
chr11: 9,573,681-9,593,457 |
|
FGF9 |
fibroblast growth factor 9 |
2254 |
P31371 |
chr13: 21,671,383-21,704,498 |
|
TTK |
TTK protein kinase |
7272 |
P33981 |
chr6: 80,003,887-80,042,527 |
|
BTC |
betacellulin |
685 |
P35070 |
chr4: 74,744,759-74,794,686 |
|
TIE1 |
tyrosine kinase with immunoglobulin-like and EGF-like domains 1 |
7075 |
P35590 |
chr1: 43,300,993-43,323,108 |
|
FLT4 |
fms-related tyrosine kinase 4 |
2324 |
P35916 |
chr5: 180,601,506-180,649,624 |
|
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
5605 |
P36507 |
chr19: 4,090,321-4,124,129 |
|
STAT5A |
signal transducer and activator of transcription 5A |
6776 |
P42229 |
chr17: 42,287,547-42,311,943 |
|
ABL2 |
ABL proto-oncogene 2, non-receptor tyrosine kinase |
27 |
P42684 |
chr1: 179,099,327-179,229,684 |
|
IL12RB1 |
interleukin 12 receptor subunit beta 1 |
3594 |
P42701 |
chr19: 18,058,995-18,098,944 |
|
CLK2 |
CDC like kinase 2 |
1196 |
P49760 |
chr1: 155,262,868-155,278,491 |
|
STAT5B |
signal transducer and activator of transcription 5B |
6777 |
P51692 |
chr17: 42,199,168-42,276,707 |
|
JAK3 |
Janus kinase 3 |
3718 |
P52333 |
chr19: 17,824,780-17,848,071 |
|
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
5608 |
P52564 |
chr17: 69,414,698-69,543,331 |
|
EPHA5 |
EPH receptor A5 |
2044 |
P54756 |
chr4: 65,319,563-65,670,495 |
|
EPHB4 |
EPH receptor B4 |
2050 |
P54760 |
chr7: 100,802,565-100,827,521 |
|
EPHB1 |
EPH receptor B1 |
2047 |
P54762 |
chr3: 134,597,801-135,260,467 |
|
EPHA4 |
EPH receptor A4 |
2043 |
P54764 |
chr2: 221,418,027-221,574,202 |
|
IL5RA |
interleukin 5 receptor subunit alpha |
3568 |
Q01344 |
chr3: 3,066,326-3,126,613 |
|
ROR1 |
receptor tyrosine kinase-like orphan receptor 1 |
4919 |
Q01973 |
chr1: 63,774,022-64,181,498 |
|
NRG1 |
neuregulin 1 |
3084 |
Q02297 |
chr8: 31,639,386-32,767,959 |
|
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
5604 |
Q02750 |
chr15: 66,386,817-66,492,312 |
|
TEK |
TEK tyrosine kinase, endothelial |
7010 |
Q02763 |
chr9: 27,109,141-27,230,175 |
|
PTK2 |
protein tyrosine kinase 2 |
5747 |
Q05397 |
chr8: 140,657,900-141,002,216 |
|
PRKCD |
protein kinase C, delta |
5580 |
Q05655 |
chr3: 53,156,009-53,192,717 |
|
TYRO3 |
TYRO3 protein tyrosine kinase |
7301 |
Q06418 |
chr15: 41,557,675-41,583,586 |
|
EFEMP1 |
EGF containing fibulin-like extracellular matrix protein 1 |
2202 |
Q12805 |
chr2: 55,865,967-55,924,139 |
|
MERTK |
MER proto-oncogene, tyrosine kinase |
10461 |
Q12866 |
chr2: 111,898,479-112,029,561 |
|
MAP2K5 |
mitogen-activated protein kinase kinase 5 |
5607 |
Q13163 |
chr15: 67,542,709-67,807,123 |
|
CUX1 |
cut-like homeobox 1 |
1523 |
Q13948 |
chr7: 101,815,904-102,283,957 |
|
MELK |
maternal embryonic leucine zipper kinase |
9833 |
Q14680 |
chr9: 36,572,862-36,677,683 |
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
2066 |
Q15303 |
chr2: 211,375,717-212,538,841 |
|
TESK1 |
testis-specific kinase 1 |
7016 |
Q15569 |
chr9: 35,605,305-35,610,041 |
|
CDC37 |
cell division cycle 37 |
11140 |
Q16543 |
chr19: 10,391,134-10,420,121 |
|
NTRK2 |
neurotrophic tyrosine kinase, receptor, type 2 |
4915 |
Q16620 |
chr9: 84,668,551-85,027,070 |
|
DSTYK |
dual serine/threonine and tyrosine protein kinase |
25778 |
Q6XUX3 |
chr1: 205,142,505-205,211,566 |
|
SGK223 |
Tyrosine-protein kinase SgK223 |
157285 |
Q86YV5 |
chr8: 8,317,736-8,386,498 |
|
ABI1 |
abl interactor 1 |
10006 |
Q8IZP0 |
chr10: 26,746,593-26,861,087 |
|
TTN |
titin |
7273 |
Q8WZ42 |
chr2: 178,525,989-178,830,802 |
|
DYRK2 |
dual specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
8445 |
Q92630 |
chr12: 67,648,338-67,665,406 |
|
SCYL1 |
SCY1-like, kinase-like 1 |
57410 |
Q96KG9 |
chr11: 65,525,077-65,538,704 |
|
NEK1 |
NIMA-related kinase 1 |
4750 |
Q96PY6 |
chr4: 169,392,857-169,612,629 |
|
HBEGF |
heparin-binding EGF-like growth factor |
1839 |
Q99075 |
chr5: 140,332,843-140,346,631 |
|
CLK4 |
CDC like kinase 4 |
57396 |
Q9HAZ1 |
chr5: 178,602,664-178,630,615 |
|
FGFR1OP2 |
FGFR1 oncogene partner 2 |
26127 |
Q9NVK5 |
chr12: 26,938,383-26,966,650 |
|
ABI2 |
abl-interactor 2 |
10152 |
Q9NYB9 |
chr2: 203,328,219-203,447,723 |
|
ZMYM2 |
zinc finger, MYM-type 2 |
7750 |
Q9UBW7 |
chr13: 19,958,670-20,091,829 |
|
EPHA6 |
EPH receptor A6 |
285220 |
Q9UF33 |
chr3: 96,814,581-97,752,460 |
|
BAZ1B |
bromodomain adjacent to zinc finger domain 1B |
9031 |
Q9UIG0 |
chr7: 73,440,398-73,522,278 |